Arteriosclerosis, Thrombosis, and Vascular Biology. 1995;15:1812-1818
© 1995 American Heart Association, Inc.
Articles |
Serum Paraoxonase Activity, Concentration, and Phenotype Distribution in Diabetes Mellitus and Its Relationship to Serum Lipids and Lipoproteins
From the University Department of Medicine, Manchester Royal Infirmary (UK).
Correspondence to Michael I. Mackness, Department of Medicine, University of Manchester, Manchester Royal Infirmary, Oxford Rd, Manchester M13 9WL, UK.
Abstract Human serum paraoxonase is physically associated with HDL and has been implicated in the detoxification of organophosphates and possibly in the prevention of LDL lipid peroxidation. We investigated the serum activity and concentration of paraoxonase in 78 patients with type 1 diabetes mellitus, 92 with type 2 diabetes, and 82 nondiabetic control subjects. Paraoxonase activity was generally lower in diabetics than in control subjects. This decrease was unrelated to differences in paraoxonase phenotype distribution or its serum concentration. Rather, the difference in paraoxonase activity was explained by its specific activity, which was lower in diabetics, indicating either the presence of a circulating inhibitor or disturbance of the interaction of paraoxonase with HDL affecting its activity. Paraoxonase specific activity was lowest in patients with peripheral neuropathy, suggesting an association of paraoxonase with neuropathy. In control subjects but not patients with diabetes, paraoxonase correlated with HDL cholesterol and apolipoprotein A-1. Our results indicate that the low paraoxonase activity in diabetes is due to decreased specific activity. In other studies low serum paraoxonase activity has been associated with increased susceptibility to atherosclerosis, and the present results also suggest an association with peripheral neuropathy, which could be due to reduced capacity to detoxify lipid peroxides in diabetes.
Key Words: paraoxonase • high-density lipoprotein • apolipoprotein A-1 • neuropathy • diabetes mellitus
This article has been cited by other articles:
 |
|
 |
|
  O. Tarcin, D. G. Yavuz, B. Ozben, A. Telli, A. V. Ogunc, M. Yuksel, A. Toprak, D. Yazici, S. Sancak, O. Deyneli, et al. Effect of Vitamin D Deficiency and Replacement on Endothelial Function in Asymptomatic Subjects J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 4023 - 4030. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Jaichander, K. Selvarajan, M. Garelnabi, and S. Parthasarathy Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin J. Lipid Res., October 1, 2008; 49(10): 2142 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. H. Gallego, M. E. Craig, A. C. Duffin, B. Bennetts, A. J. Jenkins, S. Hofer, A. Lam, and K. C. Donaghue Association Between p.Leu54Met Polymorphism at the Paraoxonase-1 Gene and Plantar Fascia Thickness in Young Subjects With Type 1 Diabetes Diabetes Care, August 1, 2008; 31(8): 1585 - 1589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. V. Poulakou, K. I. Paraskevas, I. S. Vlachos, S.-A. P. Karabina, M. R. Wilson, D. C. Iliopoulos, S. I. Tsitsilonis, D. P. Mikhailidis, and D. N. Perrea Effect of Statins on Serum Apolipoprotein J and Paraoxonase-1 Levels in Patients With Ischemic Heart Disease Undergoing Coronary Angiography Angiology, May 1, 2008; 59(2): 137 - 144. [Abstract] [PDF]
|
|
|
|
|
|
P. W. Connelly, G. F. Maguire, C. M. Picardo, J. F. Teiber, and D. Draganov Development of an immunoblot assay with infrared fluorescence to quantify paraoxonase 1 in serum and plasma J. Lipid Res., January 1, 2008; 49(1): 245 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Rector, S. O. Warner, Y. Liu, P. S. Hinton, G. Y. Sun, R. H. Cox, C. S. Stump, M. H. Laughlin, K. C. Dellsperger, and T. R. Thomas Exercise and diet induced weight loss improves measures of oxidative stress and insulin sensitivity in adults with characteristics of the metabolic syndrome Am J Physiol Endocrinol Metab, August 1, 2007; 293(2): E500 - E506. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Deakin, X. Moren, and R. W. James HDL Oxidation Compromises its Influence on Paraoxonase-1 Secretion and its Capacity to Modulate Enzyme Activity Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1146 - 1152. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Graner, R. W. James, J. Kahri, M. S. Nieminen, M. Syvanne, and M.-R. Taskinen Association of Paraoxonase-1 Activity and Concentration With Angiographic Severity and Extent of Coronary Artery Disease J. Am. Coll. Cardiol., June 20, 2006; 47(12): 2429 - 2435. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Charlton-Menys, Y. Liu, and P. N. Durrington Semiautomated Method for Determination of Serum Paraoxonase Activity Using Paraoxon as Substrate Clin. Chem., March 1, 2006; 52(3): 453 - 457. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Dursun, E. Demirtas, A. Bayrak, and H. Yarali Decreased serum paraoxonase 1 (PON1) activity: an additional risk factor for atherosclerotic heart disease in patients with PCOS? Hum. Reprod., January 1, 2006; 21(1): 104 - 108. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Ferretti, T Bacchetti, F Principi, F Di Ludovico, B Viti, V A Angeleri, M Danni, and L Provinciali Increased levels of lipid hydroperoxides in plasma of patients with multiple sclerosis: a relationship with paraoxonase activity Multiple Sclerosis, December 1, 2005; 11(6): 677 - 682. [Abstract] [PDF]
|
|
|
|
|
|
L. S. Rozek, T. S. Hatsukami, R. J. Richter, J. Ranchalis, K. Nakayama, L. A. McKinstry, D. A. Gortner, E. Boyko, G. D. Schellenberg, C. E. Furlong, et al. The correlation of paraoxonase (PON1) activity with lipid and lipoprotein levels differs with vascular disease status J. Lipid Res., September 1, 2005; 46(9): 1888 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Ferre, J. Camps, J. Marsillach, B. Mackness, M. Mackness, B. Coll, M. Tous, and J. Joven Comparison of Paraoxonase 1 Measurements in Serum and in Lithium-Heparin-Anticoagulated Plasma Samples Clin. Chem., May 1, 2005; 51(5): 922 - 923. [Full Text] [PDF]
|
|
|
|
|
|
M.-C. B. Garin, B. Kalix, A. Morabia, and R. W. James Small, Dense Lipoprotein Particles and Reduced Paraoxonase-1 in Patients with the Metabolic Syndrome J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2264 - 2269. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Hansel, P. Giral, E. Nobecourt, S. Chantepie, E. Bruckert, M. J. Chapman, and A. Kontush Metabolic Syndrome Is Associated with Elevated Oxidative Stress and Dysfunctional Dense High-Density Lipoprotein Particles Displaying Impaired Antioxidative Activity J. Clin. Endocrinol. Metab., October 1, 2004; 89(10): 4963 - 4971. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Ferretti, T. Bacchetti, D. Busni, R. A. Rabini, and G. Curatola Protective Effect of Paraoxonase Activity in High-Density Lipoproteins against Erythrocyte Membranes Peroxidation: A Comparison between Healthy Subjects and Type 1 Diabetic Patients J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 2957 - 2962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Kopprasch, J. Pietzsch, E. Kuhlisch, and J. Graessler Lack of Association between Serum Paraoxonase 1 Activities and Increased Oxidized Low-Density Lipoprotein Levels in Impaired Glucose Tolerance and Newly Diagnosed Diabetes Mellitus J. Clin. Endocrinol. Metab., April 1, 2003; 88(4): 1711 - 1716. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Kopprasch, J. Pietzsch, E. Kuhlisch, K. Fuecker, T. Temelkova-Kurktschiev, M. Hanefeld, H. Kuhne, U. Julius, and J. Graessler In Vivo Evidence for Increased Oxidation of Circulating LDL in Impaired Glucose Tolerance Diabetes, October 1, 2002; 51(10): 3102 - 3106. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E Y Sozmen, B Mackness, B Sozmen, P Durrington, F K Girgin, L Aslan, and M Mackness Effect of organophosphate intoxication on human serum paraoxonase Human and Experimental Toxicology, May 1, 2002; 21(5): 247 - 252. [Abstract] [PDF]
|
|
|
|
|
|
S. Deakin, I. Leviev, V. Nicaud, M.-C. B. Meynet, L. Tiret, and R. W. James Paraoxonase-1 L55M Polymorphism Is Associated with an Abnormal Oral Glucose Tolerance Test and Differentiates High Risk Coronary Disease Families J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1268 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Deakin, I. Leviev, M. Gomaraschi, L. Calabresi, G. Franceschini, and R. W. James Enzymatically Active Paraoxonase-1 Is Located at the External Membrane of Producing Cells and Released by a High Affinity, Saturable, Desorption Mechanism J. Biol. Chem., February 1, 2002; 277(6): 4301 - 4308. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. K. Shah, S. Kaul, J. Nilsson, and B. Cercek Exploiting the Vascular Protective Effects of High-Density Lipoprotein and its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part II Circulation, November 13, 2001; 104(20): 2498 - 2502. [Full Text] [PDF]
|
|
|
|
|
|
P. K. Shah, S. Kaul, J. Nilsson, and B. Cercek Exploiting the Vascular Protective Effects of High-Density Lipoprotein and Its Apolipoproteins: An Idea Whose Time for Testing Is Coming, Part I Circulation, November 6, 2001; 104(19): 2376 - 2383. [Full Text] [PDF]
|
|
|
|
|
|
B. Mackness, G. K. Davies, W. Turkie, E. Lee, D. H. Roberts, E. Hill, C. Roberts, P. N. Durrington, and M. I. Mackness Paraoxonase Status in Coronary Heart Disease: Are Activity and Concentration More Important Than Genotype? Arterioscler Thromb Vasc Biol, September 1, 2001; 21(9): 1451 - 1457. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. N. Durrington, B. Mackness, and M. I. Mackness Paraoxonase and Atherosclerosis Arterioscler Thromb Vasc Biol, April 1, 2001; 21(4): 473 - 480. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. J. Kudchodkar, A. G. Lacko, L. Dory, and T. V. Fungwe Dietary Fat Modulates Serum Paraoxonase 1 Activity in Rats J. Nutr., October 1, 2000; 130(10): 2427 - 2433. [Abstract] [Full Text]
|
|
|
|
|
|
R. Schmidt, H. Schmidt, F. Fazekas, P. Kapeller, G. Roob, A. Lechner, G. M. Kostner, and H.-P. Hartung MRI Cerebral White Matter Lesions and Paraoxonase PON1 Polymorphisms : Three-Year Follow-Up of the Austrian Stroke Prevention Study Arterioscler Thromb Vasc Biol, July 1, 2000; 20(7): 1811 - 1816. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. W. James, I. Leviev, and A. Righetti Smoking Is Associated With Reduced Serum Paraoxonase Activity and Concentration in Patients With Coronary Artery Disease Circulation, May 16, 2000; 101(19): 2252 - 2257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C Aubo, M Senti, J Marrugat, M Tomas, J Vila, J Sala, and R Masia Risk of myocardial infarction associated with Gln/Arg 192 polymorphism in the human paraoxonase gene and diabetes mellitus Eur. Heart J., January 1, 2000; 21(1): 33 - 38. [Abstract] [PDF]
|
|
|
|
|
|
M. S. Gowri, D. R. Van der Westhuyzen, S. R. Bridges, and J. W. Anderson Decreased Protection by HDL From Poorly Controlled Type 2 Diabetic Subjects Against LDL Oxidation May Be Due to the Abnormal Composition of HDL Arterioscler Thromb Vasc Biol, September 1, 1999; 19(9): 2226 - 2233. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Forte, M. N. Oda, L. Knoff, B. Frei, J. Suh, J. A. K. Harmony, W. D. Stuart, E. M. Rubin, and D. S. Ng Targeted disruption of the murine lecithin:cholesterol acyltransferase gene is associated with reductions in plasma paraoxonase and platelet-activating factor acetylhydrolase activities but not in apolipoprotein J concentration J. Lipid Res., July 1, 1999; 40(7): 1276 - 1283. [Abstract] [Full Text]
|
|
|
|
|
|
W. H. F. Sutherland, R. J. Walker, S. A. de Jong, A. M. van Rij, V. Phillips, and H. L. Walker Reduced Postprandial Serum Paraoxonase Activity After a Meal Rich in Used Cooking Fat Arterioscler Thromb Vasc Biol, May 1, 1999; 19(5): 1340 - 1347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Ayub, M. I. Mackness, S. Arrol, B. Mackness, J. Patel, and P. N. Durrington Serum Paraoxonase After Myocardial Infarction Arterioscler Thromb Vasc Biol, February 1, 1999; 19(2): 330 - 335. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Aviram, S. Billecke, R. Sorenson, C. Bisgaier, R. Newton, M. Rosenblat, J. Erogul, C. Hsu, C. Dunlop, and B. La Du Paraoxonase Active Site Required for Protection Against LDL Oxidation Involves Its Free Sulfhydryl Group and Is Different From That Required for Its Arylesterase/Paraoxonase Activities : Selective Action of Human Paraoxonase Allozymes Q and R Arterioscler Thromb Vasc Biol, October 1, 1998; 18(10): 1617 - 1624. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Schmidt, R. Schmidt, K. Niederkorn, A. Gradert, M. Schumacher, N. Watzinger, H.-P. Hartung, and G. M. Kostner Paraoxonase PON1 Polymorphism Leu-Met54 Is Associated With Carotid Atherosclerosis : Results of the Austrian Stroke Prevention Study Stroke, October 1, 1998; 29(10): 2043 - 2048. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Yoshida, T. Ishikawa, and H. Nakamura Vitamin E/Lipid Peroxide Ratio and Susceptibility of LDL to Oxidative Modification in Non–Insulin-Dependent Diabetes Mellitus Arterioscler Thromb Vasc Biol, July 1, 1997; 17(7): 1438 - 1446. [Abstract] [Full Text]
|
|
|
|
|
|
D. K. Sanghera, N. Saha, C. E. Aston, and M. I. Kamboh Genetic Polymorphism of Paraoxonase and the Risk of Coronary Heart Disease Arterioscler Thromb Vasc Biol, June 1, 1997; 17(6): 1067 - 1073. [Abstract] [Full Text]
|
|
|
|
|
|
B. J. Van Lenten, A. C. Wagner, M. Navab, and A. M. Fogelman Oxidized Phospholipids Induce Changes in Hepatic Paraoxonase and ApoJ but Not Monocyte Chemoattractant Protein-1 via Interleukin-6 J. Biol. Chem., January 12, 2001; 276(3): 1923 - 1929. [Abstract] [Full Text] [PDF]
|
|